BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19453040)

  • 1. Randomized, controlled study of continuous 5-FU infusion starting immediately after curative surgery for advanced colorectal cancer.
    Koda K; Saito N; Ochia T; Miyazaki M; Sarashina H; Nakajima N
    Hepatogastroenterology; 2009; 56(89):116-9. PubMed ID: 19453040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer].
    Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
    Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
    J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The usefulness of pre- and immediately postoperative chemotherapy in colorectal cancer].
    Kawahara H; Hirai K; Ashikaga K; Yamada Y; Kimura C; Kuroda H; Sato K; Ono M; Aoki T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1215-9. PubMed ID: 8031164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of pharmacokinetic modulating chemotherapy (PMC) for the postoperative adjuvant therapy of colorectal carcinoma: a preliminary report].
    Suzuka I; Izumi S; Onoda Y; Shiota K; Nishihara M; Nakagawa J; Shimizu N
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2183-8. PubMed ID: 10635302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
    Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration and dosage of fluorouracil (5-FU) continuous i.v. infusion in patients with non-curative resected/non-resected gastric cancer].
    Yamaguchi A; Isogai M; Hori A; Kawai M; Yamaguchi R; Kubota T; Yamada T; Maeda A
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):567-72. PubMed ID: 8678514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    J Surg Oncol; 2006 Jul; 94(1):45-50. PubMed ID: 16788943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review of comparative studies of postoperative adjuvant chemotherapy after curatively resected colorectal cancer in Japan].
    Mori T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1532-9. PubMed ID: 12355939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and post-operative adjuvant chemotherapy in colorectal cancer.
    Isomoto H; Tomita M; Sugimachi K; Ogawa M; Yamada K; Nakagoe T; Mori M; Takano S; Kakegawa T;
    Int J Oncol; 2003 Oct; 23(4):1103-8. PubMed ID: 12963991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiotherapy with 5-fluorouracil by bolus.
    Pasetto LM; Sinigaglia G; Basso U; Cocchio S; Compostella A; Pucciarelli S; Friso ML; Rugge M; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(6B):4095-100. PubMed ID: 19192666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized study comparing 5-fluorouracil continuous infusion (ci) plus 1-hexylcarbamoyl-5-fluorouracil and 5-FU ci alone in colorectal cancer.
    Kotake K; Ohashi Y; Kodaira S; Koyama Y;
    Oncol Rep; 2005 Jul; 14(1):129-34. PubMed ID: 15944779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
    Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
    Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor proliferation and apoptosis after preoperative hepatic and regional arterial infusion chemotherapy in prevention of liver metastasis after colorectal cancer surgery].
    Zhong YS; Lü SX; Xu JM
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(16):1229-33. PubMed ID: 19094597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.